3035 Vascular Disrupting Agent ASA 404 evaluated in human isolated ventilated and perfused lung lobes containing NSCLC. (September 2015) - Hohenberger, P.; Elleni, S.; Marc, F.; Eva, R.; Peter, F.; Alexander, M.; Benito, Y.; Nowak, K.